SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose - Unleashing tools to accelerate breakthroughs in human health – today announced that it will report third quarter 2023 financial results on Tuesday, November 7, 2023, after the close of the market.…Read More
Related Posts
Northwest Biotherapeutics Q2 Earnings Snapshot Federal News Network
BETHESDA, Md. (AP) -- BETHESDA, Md. (AP) -- Northwest Biotherapeutics Inc. (NWBO) on Wednesday reported a loss of $14.4 million in its second quarter.
Intellia Therapeutics Inc Intellia Therapeutics Names Bill Chase to its Board of Directors
CAMBRIDGE, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, today announced the…
Recursion to Participate in Upcoming Investor Conferences Recursion Pharmaceuticals NASDAQRXRX
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion RXRX, a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor…
